No. | Sex | Age (year) | Signs and symptoms | Tumor location | Surgical approach | Extent of resection | Radiology | Postoperative complications | Immuno-histochemistry | PFS (mo) | Recurrence |
---|---|---|---|---|---|---|---|---|---|---|---|
1 | M | 46 | Dizzy | Suprasellar | Craniotomy | GTR | Solid | Hypophysis, intracranial infection | S100(+), EMA(+), TTF-1(+), Ki-67 (2%) | 12 | No |
2 | F | 46 | None | Suprasellar | Craniotomy | GTR | Solid | Hypophysis | S100(+), GFAP(+), TTF-1(+), EMA(+), CD34(+), Ki-67 (1%) | 34 | Yes |
3 | F | 47 | Headache | Intrasellar | ETS | GTR | Solid | Hypophysis, intracranial infection | GFAP(+), TTF-1(+), CD34(+), S100(+), PR(+), EMA(+), Ki-67 (1%) | 34 | No |
4 | M | 63 | Vision loss | Intrasellar and suprasellar | ETS | STR | Uneven softness and toughness | None | S100(+), GFAP(+), TTF-1(+), EMA(+), Ki-67 (1%) | 36 | Yes |
5 | M | 53 | Vision loss | Intrasellar | Craniotomy | STR | Solid | None | S100(+), GFAP(+), TTF-1(+), EMA(+), vimentin(+), Ki-67 (1%) | 88 | Yes |
6 | M | 32 | Headache with decreased vision | Suprasellar | Craniotomy | GTR | Solid | Hypophysis | GFAP(+), S100(+), EMA(+), TTF-1(+), Ki-67 (1–3%) | 24 | No |
7 | F | 51 | Vision loss | Intrasellar | Craniotomy | STR | Uneven softness and toughness | Hypophysis | GFAP(+), S100(+), EMA(+), TTF-1(+), Ki-67 (1–5%) | 22 | Yes |
8 | F | 65 | None | Intrasellar and suprasellar | Craniotomy | STR | Soft | None | S100(+), GFAP(+), TTF-1(+), EMA(+), Ki-67 (1%) | 12 | No |
9 | F | 38 | Menstrual disorder | Suprasellar | Craniotomy | STR | Solid | None | GFAP(+), S100(+), EMA(+), TTF-1(+), CD34(+), Ki-67 (4%) | 28 | No |
10 | F | 54 | Headache | Intrasellar | ETS | GTR | Soft | None | S100(+), EMA(+), TTF-1(+), CD34(+), SMA(+), Ki-67 (1–3%) | 22 | No |
11 | M | 47 | Dizzy | Suprasellar | Craniotomy | GTR | Solid | Hypophysis and anemia | S100(+), EMA(+), TTF-1(+), Ki67 (2%) | 16 | No |